News

X-ZELL Live Experience Tour wrapped

Singapore, November 2023 – X-ZELL’s first global conference tour has officially wrapped after the series’ final instalment at the Annual Scientific Meeting of the American Society of Cytopathology (ASC) in Austin, Texas, USA. Aimed at promoting X-ZELL’s Next...

X-ZELL enabling same-day diagnoses at German routine laboratory

Budapest, October 2023 – New research has shown that X-ZELL Cryoimmunostaining™ is able to facilitate same-day cancer diagnoses from minimally invasive samples in routine clinical practice PD Dr. med. Achim Battmann, MD, PhD, chief pathologist at MVZ Frankfurt, a...

X-ZELL technology used for novel T cell therapy

Singapore, September 2023 – A research team at Duke-NUS Medical School in Singapore has developed a T cell therapy that could play an important role in treating cancer recurrences after liver transplants. The new treatment, called IDRA HBV-TCR*, is able to target and...

X-ZELL announces routine lab collaboration in Germany

Frankfurt, June 2023 – X-ZELL, a pioneering company in the field of next-generation cytology, is proud to announce a strategic collaboration with the Medizinisches Versorgungszentrum für Pathologie, Zytodiagnostik und Molekularpathologie (MVZ) in Frankfurt, Germany, a...

Former Roche Diagnostics NAM CEO joins X-ZELL executive board

Singapore, August 2022 – X-ZELL is proud to announce the appointment of Michael Tillmann as member of the company’s executive board. Drawing on more than 30 years of experience in the pharmaceutical and diagnostics industry, Mr Tillmann previously held the CEO...

X-ZELL appoints new Managing Director

Singapore, March 2022 – Singaporean medical technology specialist X-ZELL has appointed Sebastian Grote as Managing Director, effective from 1 March 2022. Grote previously served as Head of Marketing & Strategy at X-ZELL and has been with the company since 2017,...

Circulating atypical cells detected in blood of lung cancer patients

Warsaw, October 2021 – New study data presented at the European Congress of Cytology – held from 3-6 Oct in Warsaw, Poland – confirmed that X-ZELL is able to detect tumour-associated circulating atypical cells in the blood of lung cancer patients  The dataset...

X-ZELL hMX™ technology now available for research

Singapore, September 2021 – X-ZELL’s widely recognised high-gradient magnetic Cell Separator (hMX™) is now available to researchers worldwide. Previously exclusive to X-ZELL, the patented system is part of the company's single-cell diagnostics platform, which is...

X-ZELL launches new Imaging Technology unit

Singapore, August 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the formation of a new, interdisciplinary Imaging Technology division. The announcement comes on the back of a new collaboration agreement with Finnish Artificial Intelligence (AI)...

X-ZELL announces strategic expansion in Europe

Lennestadt, February 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the opening of a new international office in Germany.  Recently voted the second-most innovative health-tech start-up in the world1, X-ZELL has developed a powerful platform...

X-ZELL
Next-generation cytology

© 2023 X-ZELL INC

Find Us

XZELL HQ